Download Newsletter
(Most recent on top)

  Feb 2012

  Oct 2010

  Jul 2010



  February 4, 2012

Joel Wallach, Member of BAO's Medical and Scientific Advisory Board, is the Recipient of Prestigious Klaus Schwarz Commemorative Medal

Joel Wallach, D.V.M., N.D., Member of the BAO Health Resources Medical and Scientific Advisory Board, recently received the prestigious Klaus Schwarz Commemorative Medal, sponsored by International Association of Bioinorganic Scientists (IABS). IABS was founded in 1975 as a non-profit scientific organization to provide workers in the field of "Bioinorganic Chemistry" a unifying forum for the exchange and publication of ideas. The Association's vice president was the renowned Klaus Schwarz, a leading trace element researcher best known for his discovery of the essentiality of selenium.

Candidates for the annual award are selected based on recommendation from fellow workers in the field or from members of the Editorial Board of the Association's journal, Biological Trace Element Research, or other qualified individuals. A partial list of past recipients includes: James Cecil Smith, USDA Nutrition Institute; Keshan Disease Research Groups at the Chinese Academy of Medical Sciences and Xi'an Medical College; Forrest H. Nielsen and Leslie M. Klevay, USDA Grand Forks Human Nutrition Research Center; Dolph Hatfield, National Cancer Institute; James E. Oldfield, Oregon State University Nutrition Research Institute; and Kazuo T. Suzuki, University of Chiba, Japan.

BAO Health Resources is very fortunate to have Dr. Wallach as part of its Medical and Scientific Board.


BAO Health Resources Secures the Services of a Prominent Healthcare Marketing Agency

BAO Health Resources has concluded an agreement with CME Acuity, LLC, a healthcare marketing communications firm with expertise and in-depth experience in therapeutic areas such as Oncology, CV Disease, Depression, CNS, HIV, Infectious Disease and Women's and Men's Health. Its clients include leading pharmacy companies, targeted biotechnology companies, and teaching institutions such as The Johns Hopkins University School of Medicine and Columbia University College of Physicians and Surgeons.

CME is currently in the works of developing editorial content for BAO Health Resources' product in industry-leading medical publications, as well as securing BAO's presence at top medical conferences. This is a giant step in establishing BAO's product in the marketplace in within the medical community.

  JUNE 14, 2011 VOLUME 3, NUMBER 1  

Preliminary Clinical Study Correlates FOLIUM PX to Reduction of Radioactive Metals

In a preliminary clinical study, Dr. James Privitera of Covina, California, administered the BAO Health Resources product FOLIUM PX to a group of his patients. Prior to joining the study, samples of patients' hair were obtained and analyzed for radioactive and excessive toxic (heavy) metals. The patients were divided into two groups. One group received FOLIUM PX capsules for two weeks and the other group received FOLIUM PX liquid. At the end of the study, samples of blood, hair or urine were taken from each patient and analyzed for the same radioactive toxic (heavy) metals. The results indicated a direct correlation between the FOLIUM PX product and reduction of the radioactive metals. In some patients, the radioactive metals were reduced to levels undetectable. (See the chart of results and a letter from Dr. Privitera).

Brief mention that FOLIUM PX can be taken and is very effective even after exposure to radiation, while most other products on the market must be taken prior to exposure and act only as a barrier.


Potassium Iodide Must Be Taken Prior to Radiation Exposure.
FOLIUM PX Can Be Taken Any Time and Protects More than Just the Thyroid

Following the earthquake and tsunami in Japan the world was told that the nuclear power plant in Fukushima was compromised and that radiation had escaped due to explosions inside the reactors. There was a hysterical rush to buy up all the Potassium Iodide on the market. Potassium Iodide is the only product accepted by the government to treat potential radiation exposure. There are two problems with this (largely) theoretical approach by government officials. First, it is only of benefit to the thyroid. Second, it must be taken prior to exposure to the radioactive threat. Potassium Iodide cannot remove anything once exposed.

FOLIUM PX can be taken any time. In modest amounts, it is effective protection prior to exposure. In therapeutic doses, it can be taken even after exposure to the radioactive threat. Tests in (former Soviet) Georgia have established that FOLIUM PX taken after the explosion in Chernobyl and widespread exposure to radioactive contaminants, removed the toxic isotopes and prevented fatal radiation illness suffered by many who were not fortunate enough to obtain the FOLIUM PX in time.


The Japanese Government Has Expressed Interest FOLIUM PX

The Japanese government, through their embassy, has expressed interest in the product FOLIUM PX and a meeting is being arranged between their science representatives and our scientists at the BAO Health Resources Georgia Division office, per Japanese request. G. Edward Griffin is the latest addition to the BAO Health Resources Medical and Scientific Advisory Board. Ed Griffin is a highly respected and well-known researcher, author and lecturer. He is the author of the very popular book World Without Cancer: The Story of Vitamin B-17. It details the science behind cancer and modern cancer therapies, and then with copious documentation exposes the controversial politics behind cancer research and treatment today. This small volume details with precision why conventional Western cancer therapies have been such abysmal failures. He is also the author of the timely and increasingly popular book The Creature from Jekyll Island. This latest work profiles the facts behind the establishment of the privately owned Federal Reserve System in the U.S. and how it counterfeits our currency for the advantage of the well-connected wealthy.

  OCTOBER 1, 2010 VOLUME 2, NUMBER 1  

BAO Health Resources Proudly Welcomes the Multi-Faceted
Dr. Joel Wallach, DVM, ND, to its Board of Advisors

Dr. Joel Wallach has won recognition worldwide for his important work on trace minerals and their relationship to disease. In 1991, he was nominated for a Nobel Prize for his stunning discoveries in the use of trace minerals to prevent catastrophic diseases in newborns. Involved in biomedical research and clinical medicine for over 30 years, he is the author of numerous books and peer review reference articles in the field of nutrition and pharmaceutical research. Besides being president and owner of YOUNGEVITY, a large and very successful international MLM health and nutrition company, Dr. Wallach also hosts his own nationally syndicated radio show called "Dead Doctors Don't Lie," and stays busy giving health seminars and lectures throughout the world.

The 38th Annual Cancer Control Society Convention
— A Rousing Success

The Sheraton Universal Hotel in Universal City, California, was host once again to a successful Cancer Control Society Convention on September 4-6, 2010. Frank Cousineau (President—Cancer Control Society), BAO's Board Chairman, was the intriguing and engaging MC/coordinator of the entire 3-day event. Of the 40 speakers at the 3-day symposium, each an expert in his/her field, at least one featured speaker per day was a supporter of our company: Dr. James Forsythe, MD, HMD; Mr. Frank Cuny, President of California Citizens for Health Freedom; and Dr. Tony O'Donnell, MD. Others who heard about us at the convention are poised to join us in the future (More announcements to come). A brief Director/Advisory Board meeting was held at the convention. In attendance, among others, were Dr. James Forsythe, Dr. John Toth, Dr. Joel Wallach and Mr. Frank Cuny.

Long Awaited Details on BAO President's Trip to C.C.S. Japan

BAO President/CEO Babry Oren, was honored with a personal invitation to the annual convention of The Cancer Control Society (C.C.S.), Japan, held in Tokyo in mid-July 2010. He was accompanied on his trip by Mr. Frank Cousineau, President of The Cancer Control Society, USA. Aki Moriyama, President of C.C.S., Japan expressed great interest in the BAO product, FOLIUM PX. He's also the CEO/owner of a major Asian supplement company based in Japan, whose marketing company also promotes Toyota and Honda in Asia. His company furnished us with a formal Letter of Interest toward partnering and taking the product to Japan and Asia. The Japanese press was also very interested in the product and the possibilities of its availability in Asia.

  JULY 16, 2010 VOLUME 1, NUMBER 1  

Frank Cousineau, President of the Cancer Control Society,
Joins BAO Health Resources' Board of Directors

BAO Health Resources has recently welcomed Frank Cousineau to its Board of Directors. Mr. Cousineau is the President of the Cancer Control Society, which since 1973 has been one of the most respected authorities on alternative solutions to cancer patient care. He is also the President of the International Association of Cancer Victors and Friends, whose mission is to not only ease the treatment of diagnosed cancer patients, but to research methods of living healthily given modern day environmental and nutritional challenges. Mr. Cousineau is a valuable addition to the Board, as he brings extensive knowledge and experience in Alternative Therapies, which he began investigating during his own mother's fight with cancer.

BAO Health Resources Inks Deal with Script to Screen (STS)
the Leader in Direct Response Television Marketing

Chances are you've either heard of Script to Screen's (STS's) impressive clientele, including Hooked on Phonics, Nutri-System, Estee-Lauder, Conair, and General Motors, or watched one of their successful TV infomercial campaigns for Nordic-Track, Jenny Craig, Bose, or one of numerous Guthy-Renker products. STS is one of the prominent Direct Response Television (DRT) firms in the nation, with an industry-unprecedented 70-75% success rate and numerous awards for their creative production and campaign management achievements. The reason, as STS's Vice-President wrote in the memorandum signed between STS and BAO Health Resources, "is that we are able to select the projects best suited for the format."

BAO's Advisory Board Welcomes
Renowned Health Rights Advocate, Frank Cuny

Mr. Frank Cuny, Founder and President of the non-profit organization California Citizens for Health Freedom, an affiliate of National Citizens for Health, has joined BAO's Advisory Board. Mr. Cuny's organization is a well-respected advocacy movement committed to protecting and expanding natural health choices, with a focus on California State Bills. Upon joining BAO's Advisory Board, Mr. Cuny said "I want to join BAO Health Resources because I believe that people have a right to alternative medicine." Mr. Cuny will prove to be an invaluable source for BAO's own commitment to providing quality alternative methods for optimum health.

April Trip to Republic of Georgia Results in
Successful Distribution Contracts and Exciting Product Progress

The Founder and President of BAO Health Resources has returned from a successful visit to the Republic of Georgia, where he met with the scientists who originated the product to solidify patent status and seal BAO's international distribution rights. He was also able to witness first-hand the exciting new products that will be added to BAO's branded line of goods, bringing back several samples for testing by American scientists and doctors.


| Home | Product | Disclaimer | Marketing | Participate | Directors | Advisors | News | Contact Us | Site Map |